Lv1
44 积分 2025-11-25 加入
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial
14小时前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
15小时前
已完结
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC
6天前
已完结
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1–Negative Advanced NSCLC
6天前
已完结
Osimertinib–Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy
6天前
已完结
Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer
6天前
已完结
Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
6天前
已完结
Nerves at Play: The Peripheral Nervous System in Extracranial Malignancies
18天前
已完结
SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis
19天前
已完结
[Expert consensus on application specifications of low-dose radiotherapy in solid tumors (2026 edition)]
19天前
已完结
皖公网安备34019202002308
